Market revenue in 2023 | USD 134.1 million |
Market revenue in 2030 | USD 206.1 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 90.08% in 2023. Horizon Databook has segmented the Spain implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Spanish Heart Foundation, around 30,000 individuals in Spain die due to SCA. The survival rate is low, accounting for around 5% to 10%. Due to the very low survival rate, the demand for defibrillators in the country is rapidly growing.
According to the NCBI, an estimated 750,000 adults in Spain suffer from heart failure, with an annual incidence of 2.78/1000 individuals/year. Furthermore, around 25% of all hospitalizations recorded in the country are due to HF.
In addition, the mortality rate post utilizing heart failure (HF) drugsis significantly higher than other countries, thereby ICD manufacturers can readily target the market owing to the device capability to reduce mortality in HF patients.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain implantable cardioverter defibrillators market , including forecasts for subscribers. This country databook contains high-level insights into Spain implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account